SARS-CoV-2 (COVID-19)
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
The coronavirus that causes COVID-19.
Infections
COVID-19, from mild upper respiratory infection to pneumonia and respiratory failure; post-COVID conditions.
Signs and symptoms
Fever, cough, sore throat, congestion, fatigue, muscle aches, loss of taste or smell, shortness of breath.
Antibiotic and antimicrobial resistance
Antiviral resistance is monitored and currently uncommon.
Treatment considerations
Antiviral treatment (for example nirmatrelvir-ritonavir or remdesivir) for eligible patients at higher risk, per current guidelines; supportive care.
Infection control and public health
Precautions per current CDC healthcare guidance; vaccination.

Sources
- CDC. COVID-19.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.